Literature DB >> 29745754

Modelling the influence of treatment time on the biological effectiveness of single radiosurgery treatments: derivation of "protective" dose modification factors.

Bleddyn Jones1,2, John W Hopewell2.   

Abstract

OBJECTIVE: To provide simpler models for adjusting total dose to compensate for significant variations in central nervous system radiosurgical treatment times, which vary and will influence treatment bioeffectiveness. At present, no allowance is made for time variations. A framework of simpler equations would allow radiosurgical outcomes to be analysed with respect to treatment time, and a system for dose adjustments between radioisotope and linac-based techniques with different treatment durations.
METHODS: The standard biological effective dose (BED) equations for fractionated and protracted radiations have been combined, using biexponential DNA repair kinetics, to provide the following equation:BED=x.nd(1+(ndk-dk)f(μ1T)+dkf(μ1t))+(1-x). nd(1+(ndk-dk)f(μ2T)+dkf(μ2t))for "n" isocentres (or subfractions), each treated to a variable dose "d" in time "t", the overall time-being, T, µ1, µ2, are fast and slow repair rate coefficients, with partition factors of x and (1-x), respectively and k is the alpha/beta ratio, with f(μT) being the function that summates sublethal damage repair. Thus, repair during the period of irradiation and in the time interval between each isocentre can be taken into account. Simpler monoexponential and linear models are also used.
RESULTS: The results obtained using simpler models are compared with those obtained using more complex retrospective Gamma Knife BED treatment planning by Millar et al. (2015) in a group of 23 patients on a 13 Gy physical isodose surface. The above equation provides a BED value around 3% above their minimum values, 4% below their average value and 10% below their maximum BED values. Changes in isocentre numbers used, due to treatment plan complexity, can influence total treatment time, producing variations in the BED-time data: instead of a unique curve for each "n" value, in aggregate form the data (ranging from around 20 to 140 min treatment times) can be fitted by monoexponential time functions and further approximated to a linear function for more rapid estimations. Worked examples show how dose can then be tailored to the expected treatment times in order to obtain isoeffective treatments for central nervous system tissues.
CONCLUSION: The models allow better analysis of radiosurgical treatment time data and guidance to the choice of dose to match the overall time. Although this study is based on Gamma Knife treatments, in principle the methods will also apply to any radiosurgical technique, so that dose-time compensations can be made between differing techniques. ADVANCES IN KNOWLEDGE: The new BED equation-based framework is relevant to analyse and optimise radiosurgical treatments.

Entities:  

Mesh:

Year:  2018        PMID: 29745754      PMCID: PMC6435075          DOI: 10.1259/bjr.20180111

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  20 in total

1.  Radiobiological principles: their application to γ knife therapy.

Authors:  John W Hopewell; William T Millar; Christer Lindquist
Journal:  Prog Neurol Surg       Date:  2012-01-06

2.  Increased morbidity following the introduction of remote afterloading, with increased dose rate, for cancer of the cervix.

Authors:  G Newman
Journal:  Radiother Oncol       Date:  1996-05       Impact factor: 6.280

Review 3.  The clinical radiobiology of brachytherapy.

Authors:  R G Dale; B Jones
Journal:  Br J Radiol       Date:  1998-05       Impact factor: 3.039

4.  Radical radiotherapy for carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique: the Clatterbridge technique.

Authors:  L T Tan; B Jones; J E Shaw
Journal:  Br J Radiol       Date:  1997-12       Impact factor: 3.039

5.  The use of small fraction numbers in high dose-rate gynaecological afterloading: some radiobiological considerations.

Authors:  R G Dale
Journal:  Br J Radiol       Date:  1990-04       Impact factor: 3.039

Review 6.  The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?

Authors:  J Martin Brown; David J Carlson; David J Brenner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-02-01       Impact factor: 7.038

Review 7.  The evolution of practical radiobiological modelling.

Authors:  B Jones; R G Dale
Journal:  Br J Radiol       Date:  2018-03-20       Impact factor: 3.039

Review 8.  The role of biologically effective dose (BED) in clinical oncology.

Authors:  B Jones; R G Dale; C Deehan; K I Hopkins; D A Morgan
Journal:  Clin Oncol (R Coll Radiol)       Date:  2001       Impact factor: 4.126

Review 9.  An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique.

Authors:  L T Tan; B Jones; A Gee; R E Kingston
Journal:  Br J Radiol       Date:  1997-12       Impact factor: 3.039

Review 10.  Radiobiological basis of SBRT and SRS.

Authors:  Chang W Song; Mi-Sook Kim; L Chinsoo Cho; Kathryn Dusenbery; Paul W Sperduto
Journal:  Int J Clin Oncol       Date:  2014-07-05       Impact factor: 3.402

View more
  5 in total

1.  Biologically effective dose correlates with linear tumour volume changes after upfront single-fraction stereotactic radiosurgery for vestibular schwannomas.

Authors:  Bleddyn Jones; John W Hopewell; Ian Paddick
Journal:  Neurosurg Rev       Date:  2022-03-15       Impact factor: 3.042

Review 2.  Re-irradiation for intra-thoracic tumours and extra-thoracic breast cancer: dose accumulation, evaluation of efficacy and toxicity based on a literature review.

Authors:  Dorota Gabrys; Roland Kulik; Agnieszka Namysł-Kaletka
Journal:  Br J Radiol       Date:  2021-12-08       Impact factor: 3.629

3.  The impact of unscheduled gaps and iso-centre sequencing on the biologically effective dose in Gamma Knife radiosurgery.

Authors:  Thomas Klinge; Marc Modat; Jamie R McClelland; Alexis Dimitriadis; Ian Paddick; John W Hopewell; Lee Walton; Jeremy Rowe; Neil Kitchen; Sébastien Ourselin
Journal:  J Radiosurg SBRT       Date:  2021

4.  The Impact of Insulin-Like Growth Factor Index and Biologically Effective Dose on Outcomes After Stereotactic Radiosurgery for Acromegaly: Cohort Study.

Authors:  Christopher S Graffeo; Diane Donegan; Dana Erickson; Paul D Brown; Avital Perry; Michael J Link; William F Young; Bruce E Pollock
Journal:  Neurosurgery       Date:  2020-09-01       Impact factor: 5.315

5.  Biologically effective dose correlates with linear tumor volume changes after upfront single-fraction stereotactic radiosurgery for vestibular schwannomas.

Authors:  Constantin Tuleasca; Mohamed Faouzi; Philippe Maeder; Raphael Maire; Jonathan Knisely; Marc Levivier
Journal:  Neurosurg Rev       Date:  2021-04-10       Impact factor: 3.042

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.